Antibiotics for Seven Days Noninferior for Bloodstream Infection
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Antibiotic treatment for seven days is noninferior to 14 days for hospitalized patients with bloodstream infection, according to a study published online Nov. 20 in the New England Journal of Medicine to coincide with the Critical Care Canada Forum, held from Nov. 17 to 20 in Toronto.
Nick Daneman, M.D., from the University of Toronto, and colleagues randomly assigned 3,608 hospitalized patients from 74 hospitals in seven countries who had bloodstream infections to receive antibiotic treatment for seven or 14 days (1,814 and 1,794, respectively). Death from any cause by 90 days after diagnosis of the bloodstream infection was measured as the primary outcome, with a noninferiority margin of 4 percentage points.
The researchers found that by 90 days, 14.5 and 16.1 percent of those receiving antibiotics for seven and 14 days had died, respectively, which showed the noninferiority of shorter treatment duration. In 23.1 and 10.7 percent of patients in the seven- and 14-day groups, respectively, patients were treated for longer than the assigned duration. Noninferiority was also seen in the per-protocol analysis. Across secondary clinical outcomes and prespecified subgroups defined according to patient, pathogen, and syndrome characteristics, the findings were consistent.
"Although seven days of treatment was noninferior to 14 days of treatment, further research is needed to test individualized and potentially shorter treatment durations, so that each patient receives just as long a course as is needed and to balance the benefits and possible harms of antibiotic treatment more fully," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
FDA Warns of Possible Bacteria Contamination of Tattoo Inks
FRIDAY, May 9, 2025 -- Two tattoo inks have tested positive for harmful bacteria and the use of them could lead to serious infections, according to an alert from the U.S. Food and...
Quality Improvement Program Aids Antibiotic Duration for Common Infections in Children
WEDNESDAY, May 7, 2025 -- A quality improvement program can improve recommended antibiotic duration in children for both acute otitis media (AOM) and community-acquired pneumonia...
Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
WEDNESDAY, May 7, 2025 -- Sustainable development strategies are important for helping low- and middle-income countries to address the dual challenges of climate change and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.